ArticleRevista medica del Instituto Mexicano del Seguro Social2023
[Scientific integrity faces plagiarism fabricated with the ChatGPT].
Article in Revista medica del Instituto Mexicano del Seguro Social, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Among the malpractices that undermine research integrity, plagiarism is a major threat given its frequency and evolving presentations. Plagiarism implies the intentional grabbing of texts, ideas, images, or data belonging to others and without crediting them. However, the different and even masked forms of plagiarism often difficult a clear identification. Currently, the many kinds of fraud and plagiarism account for most retractions in traditional and open access journals. Further, the rate of retracted articles is higher in the Latin American databases LILACS and Scielo than in PubMed and Web of Science. This difference has been related to the typical laxity of our culture and the lack of English writing skills of non-Anglophone researchers. These features explain the conflict experienced by Latin American students in USA where they face a stricter culture regarding academic and scientific plagiarism. In the internet era, the ease of accessing scientific literature has increased the temptation to plagiarize but this ethical breach has been countered by antiplagiarism software. Now, the so-called "paraphragiarism" prompted by paraphrasing tools exceeds the infamous "copy-paste". For instance, the innovative ChatGPT can be used for plagiarizing and paraphragiarizing. Moreover, its inclusion as coauthor in scientific papers has been banned by prestigious journals and the International Committee of Medical Journal Editors because such chatbot cannot meet the required public responsibility criterium. To avoid plagiarism, it is enough to always give due credit in the proper way. Lastly, I question the ill-fated and now prevailing conjunction of blind faith in progress and zero skepticism that prevents us from foreseeing the negative consequences of technological advances.
Indexed as
Identifiers
37995379PMC10723832W4388982301What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.